Profile data is unavailable for this security.
About the company
May & Baker Nigeria Plc. is a pharmaceutical company, which is involved in the manufacturing, selling and distribution of human pharmaceuticals, human vaccines, and consumer products. The Company provides five types of products and services, including pharmaceuticals, beverages, personal care, naturecare, and contract manufacturing. Its pharmaceuticals products include anti-diabetic, anti-hypertensive, anti-infective, anti-malaria, anxiolytic, analgesic, and cough and cold. Its beverages category includes Lily Water. Its personal care product includes SMARTANS hand and surface sanitizer. It offers contract manufacturing services of pharmaceutical products to international and domestic clients through its factory, Pharma Center. The Company operates through two segments, pharmaceuticals segment is involved in the production and sale of human pharmaceuticals and human vaccines, and the beverage segment is involved in the production of beverage drinks including bottled water.
- Revenue in NGN (TTM)27.22bn
- Net income in NGN2.26bn
- Incorporated1944
- Employees388.00
- LocationMay & Baker Nigeria PLC3/5 Sapara StreetIndustrial Estate, P M B 21049, LagosIKEJA NigeriaNGA
- Phone+234 12121290
- Fax+234 14962832
- Websitehttp://www.may-baker.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CV Sciences Inc | 26.62bn | -4.25bn | 12.96bn | 42.00 | -- | 3.08 | -- | 0.4868 | -0.0157 | -0.0157 | 0.098 | 0.0139 | 1.69 | 1.55 | 25.35 | 377,285.70 | -26.94 | -43.42 | -73.44 | -77.75 | 46.06 | 51.81 | -15.95 | -45.68 | 0.2530 | -- | 0.0114 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
| Crescita Therapeutics Inc | 20.79bn | -3.27bn | 13.06bn | 80.00 | -- | 0.6809 | -- | 0.6282 | -0.1409 | -0.1409 | 0.8891 | 0.8371 | 0.7243 | 1.29 | 9.27 | 217,537.50 | -11.40 | -0.2457 | -14.88 | -0.3059 | 55.58 | 63.41 | -15.73 | -0.3518 | 1.68 | -- | 0.0545 | -- | -25.52 | 1.05 | -330.39 | -- | -1.58 | -- |
| Anatara Lifesciences Ltd | 0.00 | -1.57bn | 13.38bn | -- | -- | 8.96 | -- | -- | -0.0098 | -0.0098 | 0.00 | 0.0071 | 0.00 | -- | -- | -- | -93.91 | -76.37 | -126.61 | -88.90 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 28.27 | -- | -- | -- |
| Kanabo Group PLC | 2.43bn | -17.41bn | 13.46bn | 17.00 | -- | 1.07 | -- | 5.55 | -0.013 | -0.013 | 0.0018 | 0.0094 | 0.1054 | 16.28 | 43.85 | 67,058.82 | -75.70 | -75.83 | -81.16 | -83.33 | 7.89 | -- | -718.33 | -1,267.35 | 2.72 | -63.43 | 0.0337 | -- | 48.42 | -- | -16.26 | -- | -- | -- |
| May & Baker Nigeria PLC | 27.22bn | 2.26bn | 13.46bn | 388.00 | 5.96 | 1.32 | 5.24 | 0.4945 | 1.31 | 1.31 | 15.77 | 5.89 | 1.40 | 2.88 | 20.82 | 74,767,460.00 | 11.61 | 7.20 | 18.83 | 10.73 | 31.67 | 34.45 | 8.30 | 8.37 | 0.6784 | -- | 0.3324 | -- | 37.46 | 18.16 | -27.34 | 25.88 | 13.37 | 8.45 |
| Acrux Ltd | 8.78bn | -6.29bn | 14.18bn | 43.00 | -- | 3.99 | -- | 1.62 | -0.02 | -0.02 | 0.028 | 0.0113 | 0.728 | -- | 2.61 | -- | -52.14 | -45.05 | -71.89 | -54.04 | 51.14 | -- | -71.62 | -114.01 | -- | -- | 0.5307 | -- | -32.11 | 8.91 | -659.16 | -- | -6.20 | -- |
| Coeptis Therapeutics Holdings Inc | 0.00 | -27.12bn | 14.20bn | 5.00 | -- | -- | -- | -- | -0.5143 | -0.5143 | 0.00 | -0.0111 | 0.00 | -- | -- | 0.00 | -284.35 | -37.29 | -709.12 | -38.23 | -- | -- | -- | -- | -- | -- | 1.22 | -- | -- | -- | 43.40 | -- | -- | -- |
| Organon Pharma Indonesia Tbk PT | 292.67bn | 11.25bn | 15.13bn | 187.00 | -- | -- | 0.9947 | 0.0517 | 29,488.80 | 29,488.80 | 767,296.60 | 283,451.20 | 1.68 | 5.89 | 4.98 | 13,880,730,000.00 | 6.47 | 11.41 | 9.80 | 15.86 | 7.49 | 12.57 | 3.84 | 6.78 | 1.35 | 43.76 | 0.004 | -- | 17.45 | 4.49 | 7.39 | 8.11 | -14.93 | -- |
